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Characterization of the Potentiation Effect of Activin on Human Erythroid
Colony Formation In Vitro
By John Vu, Li-en Shao, Joan Vaughan, Wylie Vale, and Alice L. Vu
Activin, also named FSH-releasing protein, was previously
shown to induce hemoglobin accumulation in K562 cells
and potentiate the proliferation and differentiation of CFU-
E in human bone marrow cultures. Present studies mdi-
cate that the potentiation effect of activin is lineage
specific. In addition to CFU-E, activin caused an increase in
the colony formation of BFU-E from either bone marrow or
peripheral blood. It had little effect on the colony formation
of CFU-GM and the mixed colonies from CFU-GEMM. In
serum-depleted culture, the effect of activin was shown to
be dose-dependent with doses effective at picomolar con-
centrations. The potentiation effect of activin was exerted
indirectly through mediation of both monocytes and T
T HE COMPLEXITY of hematopoietic control is becom-
ing apparent as a result of the availability of highly
purified preparations of several hematopoietic growth fac-
tons.’ Recently, a pain of related protein dimers, inhibin and
activin, had been purified to homogeneity from gonadal
fluids.2￿5 They were shown to suppress on stimulate, respec-
tively, the secretion of pituitary follicle-stimulating hor-
mone.25 We found that these two proteins could modulate
both the induction of hemoglobin accumulation in a human
erythroleukemic cell line, K562, and the colony formation of
CFU-E in human bone marrow culture in a functionally
antagonistic manner.6 It was also shown that at least the
/3-subunit of these proteins was expressed at RNA level in
bone marnows of rat.7 Recently, a protein that exhibited a
potent differentiation-inducing activity toward erythnoleu-
kemia cells was isolated from human THP- 1 cells and found
to be encoded by the same mRNA as that of the fl-subunit of
inhibin/activin.8 These data agree with each other in regard
to a possible role of activin and inhibin in erythroid differen-
tiation in vitro.6 However, the physiological significance of
inhibin and activin and their effects on different hemato-
From the Department ofMolecular and Experimental Medicine,
Research Institute ofScripps Clinic, La Jolla, CA; Clayton Foun-
dation Laboratories for Peptide Biology. The Salk Institute for
BiologicalStudies, La Jolla. CA, and the Department of Pediatrics,
University ofCalifornia at San Diego, La Jolla, CA.
Submitted July 26, 1988; accepted November 9, 1988.
Supported in part by Grants No. DK37039 and CA40186 from
the National Institutes of Health (NIH) and the Clayton Founda-
tion, California Division. W. V. is a Clayton Foundation Investiga-
tor. Activin was purified under contract NOI/HD/32826 from the
contraceptive development branch of NICHHD and characterized
with support in partfrom NIH Grant No. HD 13527.
This is publication number 5459BCR from the Research Insti-
tute ofScripps Clinic.
Address reprint requests to John Yu, MD, Department of Molec-
ular and Experimental Medicine, Research Institute of Scripps
Clinic, 10666 N Torrey Pines Rd. La Jolla, CA 92037.
The publication costs ofthis article were defrayed in part by page
charge payment. This article must therefore be hereby marked
“advertisement” in accordance with 18 U.S.C. section I 734 solely to
indicate this fact.
© 1 989 by Grune & Stratton, Inc.
0006-4971/89/7304-0020$3.00/0
lymphocytes. Activin was also found to increase specifi-
cally the proportion of DNA-synthesizing erythroid progen-
itors from both bone marrow and peripheral blood. It had
little effect on DNA synthesis in CFU-GM and in mitogen-
stimulated lymphocytes. Addition of the monocytes or I
lymphocytes to their respective depleted subpopulations of
mononuclear cells reconstituted the enhancing effect of
activin on the colony formation and DNA synthesis of
erythroid progenitors. These results strongly suggest a
specific role of activin in potentiating the proliferation and
differentiation of erythroid progenitors in vitro.
a 1989 by Grune & Stratton, Inc.
poietic lineages in human bone marrow remain to be estab-
lished. In this report, we describe the effects of activin on
different lineages of hematopoietic progenitors. We also
report an enhancing effect of activin on the percentage of
DNA-synthesizing erythroid progenitor cells and the depen-
dence of the effects of activin on the presence of accessory
cells. Preliminary results of this investigation have been
presented.9
MATERIALS AND METHODS
Purification ofactivin. Ten liters of porcine follicular fluid were
subjected to several steps of purification procedures including pre-
parative cation exchange chromatography, gel filtration, and
reverse-phase high pressure liquid chromatography (HPLC), as
previously described.4 The preparation was characterized as a I3￿J1A
homodimer with the use of sodium dodecyl sulfate (SDS)-polyacryl-
amide gel electrophoresis in the reducing and nonreducing condi-
tions.4 The structure of the purified protein was also characterized
with partial amino acid sequence4 and western immunoblotting. It
reacted specifically with antibodies directed against flA’ but not a or
fiB subunit.
Cellpreparation. Bone manrows were collected at UCSD Medi-
cal Center from nonleukemic patients who received diagnostic bone
marrow aspiration or leukemic patients who had completed chemo-
therapy for at least 6 months and remained in remission. The
mononuclear cell fraction in bone marrow was separated by centnifu-
gation over Ficoll-Paque density gradient (specific gravity 1.077
g/mL; Pharmacia Fine Chemicals, Piscataway, Ni)’#{176} at 2,000 rpm
for 30 minutes at room temperature. The mononuclear cells at the
interface were collected, washed two times with a-medium (Flow
Laboratory, Inc. McLean, VA), and resuspended in the same
medium.
Peripheral blood was collected from normal human volunteers and
was anticoagulated with preservative-free hepanin. Mononuclear
cells, which were harvested after Ficoll-Paque centnifugation, con-
sisted of approximately 65% lymphoid cells and 35% monocytes.
Adherent cells were obtained by the adherence technique described
by Shaw et al.” Briefly, mononuclear cells suspended at 1 x 106/mL
in a medium with 20% fetal calf serum (FCS) (Hycbone mc, Logan,
UT) were incubated in polystyrene tissue culture dishes for 1.5 hours
at 37#{176}C in the CO2 incubator. Nonadherent cells were removed from
the plates with pipettes. After washing with 2 mL of a medium
containing 10% FCS three or four times, the adherent cells were
removed by gentle scraping with a rubber policeman. These adhen-
ent cells, which consist of >90% monocytes as determined by
Wnight-Giemsa stain and a-naphthylbutyrate esterase staining,’2
are designated operationally in the remainder of this report as
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“monocytes.” Nonadhenent cells were obtained after two consecu-
tive 1 .5-hour incubations in plastic culture dishes. Only those cells
that were in suspension and that could be recovered by gentle
pipetting were harvested as nonadherent cells. They contained fewer
than 3% monocytes.
I lymphocytes were obtained from mononuclear cell suspensions
by rosette formation’3 with 1-aminoetylisothiouronium bromide-
treated sheep erythrocytes, followed by centnifugation on Ficoll-
Paque density gradient to collect rosette-forming cells and by
subsequent osmotic lysis of the erythrocytes.’4 The T-cell enriched
suspensions contained >90% E-nosette positive and T65 (a pan-T
cell marker) positive cells and <2% monocytes. The I-depleted
populations collected from the interface after the Ficoll-Paque
centnifugation contained < I 5% E-rosette positive I cells.
All patients were advised of procedures regarding bone marrow
aspirations and venipunctures and their attendant risks, in accor-
dance with institutional guidelines, and gave informed consent.
Culturefor erythroidprogenitors. Culture of erythnoid progeni-
ton cells was performed as described by Iscove et al with slight
modifications.’5 Briefly, 2 x l0￿ mononuclear cells from bone
marrow or 3 x l0￿ cells from peripheral blood were plated in 35-mm
Petni dishes in a I mL mixture containing a-medium, 0.8% methyl-
cellulose, 30% FCS, 2 units of erythropoietin (Step III; Connaught
Labs, Ontario, Canada), 0.1 mmol/L a-thioglycerol (Sigma), 1%
bovine serum albumin, 50 IU penicillin, and 50 zg streptomycin. The
amount of activin in each culture was specified in the text. The
dishes were incubated at 37#{176}C in a humidified incubator flushed
with 7.5% CO2 for a total of 14 days. To enumerate CFU-E derived
colonies, the dishes were examined on an invented microscope for
hemoglobinized and compact colonies with eight or more cells on day
7 of culture. BFU-E were scored on day 14 and identified as large
aggregates of 64 or more hemoglobinized cells or as clusters of three
or more subcobonies consisting of eight or more hemogbobinized cells
per subcobony. The enumeration of colony formation was performed
in a double-blinded manner. The number of erythroid progenitors
per culture plates (ie, cloning frequency) in the control bone marrow
cultures varied among different individuals; however, there was little
variation (an average of 7%) in the number of erythroid colonies
grown from the same bone marrow aspirates. In addition, in some
cases, cells grown in individual colonies of CFU-E and BFU-E were
aspirated and cytocentnifuged. Their morphology and the presence
of hemoglobin were examined with Wnight-Giemsa and benzidine
staining, respectively.
Culture for CFU-GM. Culture of GFU-GM derived colonies
was performed in 0.3% agar as described with modifications.’6”7
Briefly, 2 x I ￿S mononuclear cells from bone marrows were plated in
35-mm Petni dishes in a I mL mixture containing a-medium, 0.3%
agar, 15% human placental conditioned medium (see below), and
20% FCS. The CFU-GM derived colonies were enumerated after
ten days of culture. The average number of CFU-GM in repeated
experiments was 108 per plate. The placental conditioned medium
was prepared as described.’8 Briefly, placenta from normal deliveries
were placed immediately in cold Hanks’ solution (4#{176}C) containing
100 IU penicillin, 100 ￿zg streptomycin, and 2.5 ￿ig amphotenicin B
per milliliter. The membranes were removed and the placental
tissues cut with scissors into pieces of approximately 5 g. These
pieces of tissues were rinsed thoroughly in a sieve with saline and
then homogenized in an electric mincer for one second two times.
Then the tissues were cultured with 20 volumes of RPMI-1640
medium containing 5% FCS for seven days at 37#{176}C in a fully
humidified incubator flushed with 7.5% CO2. After incubation, the
conditioned medium was centrifuged for 30 minutes at 22,000 g at
4#{176}C, and the clear supennatant sterilized by filtration through nitrate
membranes (0.45 ￿mol/L) and stoned at -20#{176}C until use.
Culturefor CFU-GEMM. The colony culture for CFU-GEMM
used was a modification of the procedures described by Ash et ￿#{149}￿9.20
Mononuclear cells were suspended in Iscove’s modified Dulbecco’s
medium containing 0.8% methylcellulose, 30% FCS, 0.1 mmol/L
fl-mencaptoethanol, 1% bovine serum albumin, 50 IU penicillin, and
50 ￿g streptomycin per milliliter. The same batch of phytohemag-
glutinin-stimulated leukocyte-conditioned medium was used at 5%
vol/vol throughout the study. Enythropoietin was added at the start
of the culture at 1 IU/mL. All cultures were grown at 37#{176}C in 7.5%
CO2 in air for 14 days. A mixed colony was defined as a group of >50
cells containing >20% hemoglobinized cells and >20% granulo-
monocytic translucent cells. Colonies with >80% hemogbobinized
cells were referred to as erythroid colonies and >80% granubomono-
cytic cells were considered as CFU-GM. The cellular composition of
mixed and other colonies was also confirmed in some cases with
Wnight-Giemsa stain after colonies were picked individually and
stained on slides.
Serum-free culture of erythroid progenitors. The serum-free
culture of erythroid progenitor cells was performed as described by
Akahane et al.2’ Approximately 3 x I0￿ mononuclear cells were
plated in a 1 mL mixture containing Iscove’s modified Dulbecco’s
medium, 0.8% methylcellubose, 7.8 ￿tg/mL cholesterol, 5.6 ￿g/mL
oleic acid, 8 ￿zg/mL phosphatidylcholine, 200 ￿zg/mL transfernin,
3% bovine serum albumin, 2 IU/mL enythropoietin, and 0.1 mmol/
L fl-mercaptoethanol in 35-mm Petni dishes. In addition, I .7 x lO_8
mol/L insulin was also added. Cultures were incubated at 37#{176}C in a
humidified atmosphere of 7.5% CO2 in air. The CFU-E and BFU-E
were counted after seven and 14 days of incubation as described.
Proliferative activity of hematopoietic progenitor cells. The in
vitro cell suicide technique was essentially described by Axelnad et
al.22 Aliquots of i x 106 mononuclear cells per milliliter were
preincubated with 10 ng/mL of activin or other additives in a-
medium containing 20% FCS. The cell suspensions were gassed with
5% CO2 in air and incubated in stoppered tubes for 20 minutes at
room temperature with occasional mixing. After preincubation,
samples were separated into two aliquots. One aliquot was added to a
tube containing hydroxyurea (final concentration of 14 mmol/L) or
3H-thymidine (40 zCi/mL; specific activity 50 Ci/mmol) and the
other was added to a tube containing a-medium as control. All tubes
were incubated at 37#{176}C for another 45 minutes in a CO2 incubator.
After incubation, the cells were centrifuged, washed two times with
15 mL of a-medium, and plated in duplicates as described for
marrow cultures ofCFU-E, BFU-E, and CFU-GM. The percentage
of DNA-synthesizing progenitor was calculated from the equation:
C-E
-￿--- x 100
where C is the number ofcolonies in cultures from control incubation
and E is the number of colonies in cultures exposed to hydnoxyunea
or 3H-thymidine. In presenting these data, the percentage of DNA
synthesizing progenitor cells was determined from each type of
preincubation and, in order to compare the results from two types of
preincubation, the Student’s t test was used.
RESULTS
Effects of activin on various hematopoietic progeni-
tors. Activin was purified to homogeneity from porcine
follicle fluid and characterized as a ￿3￿￿J3A homodimer, as
described.4 The effects of the addition of activin on in vitro
cultures of various hematopoietic lineages were analyzed in
the present studies. As shown in Figs lA and 2A, the
addition of 5 ng/mL of activin significantly potentiated the
formation of CFU-E and BFU-E in the presence of erythro-
poietin. As in the case of CFU-E,6 the potentiation of the
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Fig i . Effects of activin on the proliferation and differentiation
of marrow CFU-E. Mononuclear cells from human bone marrow
were seeded at 1 .5 x i05/plate in the serum-containing culture
(A) and 3.75 x i05/plate in the serum-depleted culture (B). The
conditions for bone marrow cultures were described in Materials
and Methods. The amounts of activin in each culture are specified.
The results represent the averages of two independent determi-
nations for the number of CFU-E-derived colonies per plate at day
7 of the culture.
0 1 5
Activin (ng/ml)
Fig 2. Effects of activin on the proliferation and differentiation
of marrow BFU-E. Bone marrow mononuclear cells were plated at
i .5 x iO’/mL in the serum-containing culture (A) and 3.75 x
iO’/mL in the serum-depleted culture (B) with the amounts of
activin in each culture as specified and described in Materials and
Methods. The results represent the averages of two independent
determinations for the number of BFU-E-derived burst formations
per plato at day 14 of the culture.
BFU-E derived colonies by activin required the presence of
erythropoietin; activin alone did not support the formation of
BFU-E in these cultures (results not shown). It was also
found that the colony formation of BFU-E from peripheral
blood could be similarly potentiated by activin (see below).
High concentration of serum (30% FCS) was routinely used
in bone marrow cultures (Figs I A and 2A). In order to
demonstrate a dose-dependent effect of highly purified
activin on the growth of erythroid progenitors, serum was
removed from the culture medium in the following experi-
ments. As shown in Figs 1B and 2B, both CFU-E and BFU-E
grew in the serum-deprived culture and the growth of these
erythroid progenitors in the presence of erythropoietin was
potentiated by activin in a dose-dependent manner with
effective concentrations at picomolar ranges. Cultures con-
taming equal volumes of HPLC buffer used in the activin
purification did not exhibit any effects on colony formation
in similar marrow cultures (Fig 3).
To explore the lineage specificity of activin, the effects of
activin on erythroid and nonerythroid progenitor cells were
compared. Figure 3 summarizes the results of up to eight
experiments of the cultures for erythroid progenitors. The
addition ofactivin in marrow cultures significantly increased
the proliferation and differentiation of CFU-E and BFU-E
up to 171.1 ± 6.3% and 184.3 ± 6.1% of their respective
controls (Fig 3). In contrast to erythroid colonies, the num-
ben of CFU-GM derived colonies was not affected by the
addition ofactivin (Fig 3). In these experiments, the addition
of 5% to 20% of placental conditioned medium was necessary
to support the growth of CFU-GM in the bone marrow
culture. The presence of activin could neither replace nor
potentiate the effects of these conditioned media. When
mononuclear cells were cultured for CFU-GEMM in the
presence of enythropoietin, the addition of activin did not
potentiate the formation of mixed colonies and CFU-GM;
but it enhanced the formation of colonies with predominant
erythroid progeny (Fig 4).
Requirement of accessory cells for the activin
effect. The potentiation effect of activin observed in previ-
ous experiments could be exerted directly on erythroid
progenitor cells or indirectly through mediation of the acces-
sony cells present in the mononuclear cell preparations used
for cultures of erythroid colonies. In order to examine the
dependency of the activin effects on the accessory cells, the
mononuclear cell fraction was depleted either of monocytes
or E-rosetting T lymphocytes. As shown in Table 1, when
adherent monocytic cells were removed from the bone mar-
row mononuclear cells, the potentiation effects of activin on
both CFU-E and BFU-E in the nonadherent cells diminished
10 to a large extent. Based on the nonspecific esterase assay,’2
the nonadherent cell fraction contained fewer than 3% of
monocytes. Repeated experiments indicated that activin
sustained an average of 18.0 ± 4.0% and 26.2 ± 1.9% of the
potentiation effect on CFU-E and BFU-E, respectively, in
those cultures of monocyte-depleted nonadherent subpopula-
tions, over the colony formation derived from the same
subpopulation of cells without the addition of activin (not
shown).
For personal use only. on October 31, 2014.  by guest    www.bloodjournal.org From CFIJ-E BFU-E CFU-GM
250 ‘ I
03 200
Co
a,
.2 150
Co
E
0
U-
￿ 100
0
50 -
S
￿￿￿171.1±6.3
S
S f/.￿42￿23￿
I￿ I I I I I I
0 50 100
100 Number of Colonies Per Plate
50
150
BFU-E were also found to be present in the circulating
peripheral blood.23’24 As shown in Table 2, the addition of
activin potentiated the colony formation of BFU-E from
peripheral blood. Similar to the BFU-E in bone marrows,
this potentiation effect of activin on the growth of BFU-E
from peripheral blood was also reduced by removing adher-
ent cells from the mononuclear cell fraction (Table 2). The
mononuclear cell fraction isolated from peripheral blood
contained approximately 37% of estenase-positive monocytic
series. After adherence to plastic surface, monocytes were
reduced to only 3%. In experiment no. 3 in Table 2, nonad-
restore the proportion of monocytes in the mixture. Such
admixture of adherent and nonadherent cells resulted in
restoration of the potentiation effect of activin (Table 2).
Furthermore, when E-rosetting T lymphocytes were removed
from the mononuclear cells, the effect of activin largely
disappeared (Table 2). The proportion of these T lympho-
cytes was shown to be approximately 60% of the mononu-
clean cells, based on a T65 marker assay. In the reconstitu-
tion experiments, the addition of I lymphocytes to the
T-cell-depleted fraction at 1 : 1 ratio restored the response of
cells toward the addition of activin (Table 2). In a total of
three repeated experiments, the potentiation effects of 5
ng/mL of activin for the mononuclear cells from peripheral
blood after depletion of either monocytes or E-rosette T
lymphocytes were 20.9 ± 1.7% or 14.8 ± 7.3%, respectively,
over the colony formation of their controls as compared with
86.6 ± 8.5% for the unfractionated mononuclear cells (data
not shown).
Stimulation ofDNA synthesis in erythroidprogenitors by
activin. Because of the low frequency of progenitor cells
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Fig 3. Distribution of the potentiation effect of activin on
various colony formations of different bone marrow aspirates.
Bone marrow mononuclear cells were cultured in a-medium with
or without 5 ng/mL of activin (or equal volume of activin HPLC
buffer). The potentiation effect of activin was expressed as the
percentage of various colony formations relative to the number of
respective colonies grown in the control medium in the absence of
either activin or activin buffer (ie. control, 100% in the figure).
Statistical analyses were performed using Student’s t test. All
data were presented as mean values ± SE. The results indicate
that activin potentiated significantly the proliferation of both
CFU-E (P < .000i) and BFU-E (P < .000i ) and did not have an
effect on CFU-GM (P > .06). when compared with their respective
controls.
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= No Treatment
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Fig 4. Effect of activin on the proliferation and differentiation
of erythroid. CFU-GM and multilineal colonies in CFU-GEMM
cultures. Aliquots of 2 x 1O￿ mononuclear cells from human
marrows were plated for CFU-GEMM with 1 lU/mi of erythropoie-
tin and 5% (vol/vol) of phytohemagglutinin-stimulated leukocyte
conditioned medium in the absence and presence of activin, as
described in Materials and Methods. After 14 days of incubation at
37’C and 7.5% CO2. various colonies were identified with an
inverted microscope. Colonies composed of more than 80% hemo-
globinized cells were referred to as erythroid colonies and more
than 80% translucent cells as CFU-GM. A mixed colony was
defined as a group of cells consisting of >20% erythroid and 20%
granulomonocytic cells.
henent cells were admixed with adherent cells at 2: 1 ratio to
Table i . Requirement of Adherent Cells for the Effects of Activin on CFU-E and BFU-E From Human Bone Marrows
Cell
Populations
No. of CFU-E Colonies
% Increase
Relative to Control
No. of BFU-E Colonies
% Increase
Relative to Control Control Activin Control Activin
Mononuclearcells 82.0 ± 2.8 136.5 ± 7.5 166.4 98.5 ± 6.4 188.5 ± 7.8 191.4
Nonadherentcells 137.5 ± 10.6 158.0 ± 5.6 114.0 109.0 ± 5.7 135.5 ± 16.3 124.3
Mononuclear and nonadherent cells were isolated from human bone marrow as described in Materials and Methods. Based on the nonspecific esterase
1 and Wright-Giemsa stain, the nonadherent cells contained <3% of monocytes. After preparation, aliquots of 1 x 10￿ cells were cultured in the
presence of either control medium or 5 ng/mL activin, as described for CFU-E and BFU-E.
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Table 2. Reconstitution of the Potentiation Effect of Activin on BFU-E in Various Mixtures of Subpopulations of Cells
From Peripheral Blood
Cell Populations
BFU-E Colonies/Plate
% Increase
Relative to Control
..
Nonspecthc
Esterase (+) Cells (%)
T Cell
Marker (%) Control Activin
Mononuclearcells 64.0 ± 2.8 125.0 ± 18.4 195.3 37 61
Nonadherentcells 33.3 ± 2.2 39.5 ± 0.7 118.6 3 70
Nonadherent cells
+ adherentcells(2:1) 59.5 ± 2.1 106.0 ± 5.7 178.2 [85 10]
T-depleted cells 60.0 ± 5.7 72.0 ± 8.5 120.0 72 15
T-depleted
+ TcelIs(1:1) 62.0 ± 2.8 110.0 ± 7.1 177.4 [2 90]
Mononuclear cells, adherent and nonadherent cells, T lymphocytes, and T-depleted cells were obtained as described in Materials and Methods.
Various subpopulations and mixtures of cells were plated at 3 x 105/mL per plate for BFU-E culture. The nonspecific esterase assay for monocytes and
the T-ceII marker assay for T lymphocytes were performed as described. Numerical values within brackets indicate the percentages of positive cells for
either adherent cells or T cells before admixture experiments, based on the monocyte or T-celI marker assay.
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Fig 5. Effect of activin on the percentage of DNA-synthesizing hematopoietic progenitors from bone marrow. The in vitro cell suicide
assay for the DNA-synthesizing CFU-E (A). BFU-E (B). and CFU-GM (C) was described in the Materials and Methods. Aliquots of 1 x lOs
mononuclear cells were preincubated with a-medium. 10 ng/mL of activin. or equal volume of activin HPLC buffer (as specified) for 20
minutes. Then. each sample was separated into two portions for another 45 minutes incubation in the presence (U) and in the absence (0)
of 14 mmollL hydroxyurea. After incubation for a total of 65 minutes. the cells were washed and plated for specific cultures of CFU-E,
BFU-E. and CFU-GM, as described in Materials and Methods. The values of CFU-E (A). BFU-E (B). and CFU-GM (C) derived colonies per
culture plate represent the number of colonies which were obtained from each sample with or without prior treatment with
hydroxyurea. (D) The values in this figure represent the percentages of CFU-E. BFU-E. and CFU-GM which were killed by the hydroxyurea
treatment. as described above. The percentage of cells killed was calculated from the number of colonies in control cultures (without
treatment of hydroxyurea) and those cells with prior exposure to hydroxyurea. The effects of various preincubations (ie. a-medium. 10
ng/mL activin. and HPLC buffer alone) are shown in the figure.
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present in bone marrow, it is impossible to measure DNA
synthesis of these cells directly. Alternatively, the proportion
of progenitor cells in active DNA synthesis can be assessed
by the “cell suicide” method, which involves a short exposure
to either hydroxyurea or ‘H-thymidine with high specific
activity,22 and which is followed by cultures for various
surviving progenitors. Using these assays in Fig 5, the
percentages of BFU-E in the bone marrow cells sensitive to
hydroxyurea treatment after preincubation of cells with
activin were found to increase from a control value of 35% to
a value of 66% (Fig 5B and D). Similarly, the percentage of
CFU-E killed by hydroxyurea treatment after preincubation
with activin increased from 58% to 76% (Fig 5A and D). In
contrast, the addition of HPLC buffer in place of activin did
not affect DNA synthesis of CFU-E or BFU-E. Figure SC
and D also indicated that the percentage of DNA-synthesiz-
ing CFU-GM was little affected by the addition of activin.
The results of three independent experiments, which exam-
med the effect of preincubation with activin on the percent-
ages of DNA-synthesizing BFU-E, CFU-E, and CFU-GM
in bone marrows, are summarized in Table 3. In contrast to
bone marrow, BFU-E from the peripheral blood were known
to be low in DNA synthesis activity.25 But, similar to BFU-E
in bone marrow, preincubation with activin also led to
substantial augmentation of DNA synthesis in the BFU-E
from peripheral blood (Table 4).
Similar increase in the percentage of DNA-synthesizing
erythroid progenitors (but no increase in the CFU-GM) by
the addition of activin was also detected with incubation of
3H-thymidine with high specific activity (data not shown).
Therefore, these results confirmed that activin significantly
and specifically increased the proportion of the erythroid
progenitors in the S phase of cell cycle, where DNA is
synthesized. In other experiments, when adherent cells were
depleted from marrow cells, the remaining mononuclear cells
did not yield a significant increase in the proportion of
DNA-synthesizing CFU-E (also BFU-E) after preincuba-
tion of the cells with activin (data not presented). These
results confirmed the specificity of activin in the “cell
suicide” assay. They also indicated that the increase in DNA
synthesis for BFU-E and CFU-E depends on the presence of
some accessory cells.
Table 3. The Percentage of Various DNA-Synthesizing
Progenitor Cells in Bone Marrows After Preincubations
Preincubations
Percentage Cells Killed by Hy&oxyurea
CFU-E BFU-E CFU-GM
a-Medium 57.4 ± 0.3 37.9 ± 2.8 36.1 ± 5.5
Activin, lOng/mL 74.6 ± 1.2 68.0 ± 2.3 34.3 ± 4.8
Activinbuffer 53.0 ± 1.3 37.1 ± 2.5 35.3 ± 2.8
Mononuclear cells from human bone marrows were isolated and
preincubated with a-medium, 10 ng/mL of activin, or equal volume of
activin HPLC buffer. The in vitro cell suicide assay was performed as
described in Fig 5 and Materials and Methods. The values represent the
means ( ± SD) of three independent separate experiments. The Student’s
t test indicated that the observed paired differences between controls and
the activin-treated samples are statistically significant for CFU-E
(P < .03) and BFU-E (P < .01) but there are statistically no differences
for CFU-GM (P > .2).
Table 4. The Percentage of DNA-Synthesizing BFU-E in
Human Peripheral Blood
Preincubations
Number of BFU-E per Plate
% BFU-E Killed Control Hydroxyurea
a-Medium 65.0 ± 4.2 55.0 ± 1.4 15.4
Activin, lOng/mL 66.0 ± 8.4 40.5 ± 2.1 38.6
Activin buffer 63.0 ± 7.1 54.0 ± 5.6 14.3
Mononuclear cells were isolated from peripheral blood. Aliquots of
1 .5 x iOe cells were preincubated with a-medium, 10 ng/mL of activin,
or equal volume of activin HPLC buffer, and then the in vitro “cell suicide”
assay was performed for the DNA-synthesizing BFU-E. as described in
Fig 5 and Materials and Methods.
In addition, the effects of activin on the activation of DNA
synthesis in lymphoid cells were also examined. Activin was
added to the incubation mixtures of peripheral blood mono-
nuclear cells containing various mitogens and the extent of
lymphocyte activation measured by incorporation of ‘H-
thymidine into DNA after four to six days incubation. The
results obtained from ten normal individuals showed that
activin at concentrations up to 10 ng/mL did not affect the
DNA synthesis of unstimulated lymphocytes (not shown) or
the mitogen-stimulated lymphocytes. A representative
experiment is shown in Table 5.
DISCUSSION
Activin and inhibin are two related molecules with dif-
ferent subunit associations and functionally opposite activi-
ties.2￿28 Our laboratories6’9 previously had reported that these
two proteins constituted a novel humoral regulatory control
of erythropoiesis. It was recently reported that there is
significant homology of the primary structure and the distri-
bution of cysteine residues between the fl-subunit of inhibin/
activin and the human transforming growth factor-fl (TGF-
fl)27 Based on sequence homology these inhibin/activin
related proteins now constitute a new family of growth
factors, which include the Mullerian inhibiting substance,29
Drosophila decapentaplegic gene complex,’#{176} and Xenopus
Table 5. Effects of Activin on the DNA Synthesis of Lymphocytes
in Response to Various Mitogens
Treatments
Percentage Thymidine lncorp￿ation Relative to Controls
PHA Con A Pokeweed Staphylococcus
Control medium
Activin
HPLC buffer
100 100 100 100
95 ± 11 92 ± 11 103 ± 6 122 ± 17
104 ± 8 97 ± 13 105 ± 2 86 ± 19
Mononuclear cells from peripheral blood were plated in triplicate at
1 x ￿ cells per well in 100 zL of RPMI 1640 medium containing 10%
FCS to microtiter plates together with various mitogens and the presence
or absence of 10 ng/mL activin or HPLC buffer. The concentrations of
mitogens and time of incubation were: phytohemagglutinin A (PHA). 2.5
ag/mL, and concanavalin A (Con A), 10 ￿xg/mL, for four days; pokeweed
mitogen, 2.5 ag/mL, and Staphylococcus Cowan I, 0.01 25%, for six
days. During the final two hours of incubation, 2 MCi of 3H-thymidine was
added to each well. The incorporation of 3H-thymidine was then
measured by collecting the cells onto glass fiber filters, washing the filters
with water, and counting the radioactivity in a liquid scintillation counter.
The results were expressed as percentage of 3H-thymidine incorporation
relative to controls without mitogens or activin.
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Vgl .￿ This family of related molecules may exert a wide
range of cellular responses in different cell types.
In the present studies, activin was further shown to
stimulate specifically the proliferation and differentiation of
enythroid progenitors in the presence of erythropoietin, but
not of CFU-GM. Activin enhanced the growth of erythroid
progenitor cells in both serum-containing and serum-
depleted cultures. Its stimulatory effect was also concentra-
tion dependent. On the other hand, activin could not replace
or potentiate the effect of placental conditioned medium on
the growth of CFU-GM. The results of CFU-GEMM cul-
tunes also agreed that activin could potentiate specifically the
growth of erythroid colonies but not the mixed colonies.
Furthermore, in the mouse system, we had shown that activin
did not have effect on the megakanyotic progenitors (manu-
script in preparation). Therefore, the effect of activin on
hematopoiesis in vitro is apparently restricted to erythroid
lineage. However, a possible effect of activin on nonerythnoid
cells remains to be ruled out, because such an effect may be
obscured by the use of conditioned medium, which contained
sufficient amounts of colony stimulatory factors required for
the maximal growth of nonerythroid colonies.
The potentiation effect of activin may be attributed to the
increase in the proliferative state of BFU-E and CFU-E in
the bone marrow cultures. Alternatively, activin may drive
the differentiation of progeny of these progenitors to form
hemoglobinized cells, thus rendering the colonies recogniz-
able as an erythroid colony. Another possibility is that both
mechanisms may be operative on the growth of erythroid
progenitors. It was previously reported that activin had
differentiation-inducing effect on K562 and Friend cells.6’8 It
is thus conceivable that activin may have effects on both
cellular proliferation and differentiation as well. Present
studies indicate that activin could stimulate proliferation of
erythroid progenitor cells by increasing the proportion of
cells actively engaged in DNA synthesis. The proliferative
state of various progenitors was analyzed using two S-phase
specific agents, which share the common feature in killing
those DNA-synthesizing cells.22 In combination with specific
culture systems, such “cell suicide” method could yield
information about cellular cycling of particular lineages in a
heterogeneous population. Based on these assays, it was
shown that many BFU-E are in a quiescent, non-DNA
synthesizing state.32 Present studies indicate that the addi-
tion of activin resulted in a significant increase in the
proportion of DNA-synthesizing BFU-E in bone marrow and
peripheral blood. On the other hand, 57% ofCFU-E from the
bone marrow cells of the untreated controls are in the DNA
synthesis phase of the cell cycle in the present studies.32 With
a large proportion of CFU-E in control samples already
engaged in cell cycling, the enhancing effect of activin
toward the increase of CFU-E in S phase of cell cycle is less
prominent than that for BFU-E; but it is still significant. It is
unlikely that such enhancing effect of activin on cycling
BFU-E and CFU-E is a consequence of nonspecific pertun-
bation of incubation condition during the “cell suicide”
assay. The specificity of its enhancing effect on DNA
synthesizing progenitor cells was demonstrated by its lack of
similar stimulation toward CFU-GM and its dependency on
accessory cells. Such dependency was also demonstrated in
its potentiation effect on the growth of erythroid progenitors
(see below). Therefore, it is concluded that activin caused a
specific increase in the percentage of DNA synthesizing
CFU-E and BFU-E cells, which could lead to an increase in
the colony formation of erythroid progenitors when cultured
in the presence of activin.
The increase in the percentage of cells engaged in DNA
synthesis suggests that activin may act by triggering entry of
resting progenitors into the S phase of the cell cycle. The
effect of activin on the enhancement of DNA synthesis had a
rapid onset, since it was observed after a total of only
approximately one hour incubation of marrow cells with
activin. The rapidity with which erythroid progenitors could
enter the S phase of the cell cycle implies that the cells out of
cycle (designated as G0 cells) are actually arrested at the end
of the G, phase (ie, close to the G,/S boundary). This rapid
response of DNA synthesis toward the addition of activin is
in contrast to the long delay observed for the onset of DNA
synthesis in the activation of T lymphocytes or fibroblasts by
antigens or serum growth factors, respectively.”4 It was
previously shown that incubation with erythropoietin took
approximately five to six hours before an increase in DNA
synthesis was observed.” Furthermore, it should be noted
that in these assays, the samples were washed thoroughly
before culture for surviving BFU-E and CFU-E and there
was no increase in the number of erythroid colonies because
activin was not present in these cultures. The increase in the
percentage ofcells killed in the suicide assays thus refers only
to the increase of DNA synthesis as a consequence of the
preincubation with activin. The washing procedure, which
followed hydroxyurea treatment, should well remove activin
and thus its enhancing effect in the subsequent cell cultures
subsided. In other words, the potentiation effect of activin on
DNA-synthesis is a reversible process. The “rapidity” and
the “reversibility” of the activin enhancing effect on DNA
synthesis are thus reminiscent of the observations by Axelnad
et al, in which the effects of their “negative regulatory
protein” on DNA synthesis of mouse BFU-E are both rapid
and reversible.32 Our observations are also consistent with
the proposal that the proliferative state of the erythroid
progenitors is not a static condition; it may be continually
maintained by interactions on the surface of these progeni-
tons with both negative and positive regulators.
Activin potentiated the proliferation and differentiation of
erythroid progenitors only in the presence of erythropoietin.
Its effect was mediated through the cooperation of both
monocytes and T lymphocytes. Addition of the monocytes or
T lymphocytes to their respective depleted subpopulations of
mononuclear cells reconstituted the enhancing effect of
activin on the colony formation of the enythroid progenitors.
Similarly, the enhancing effect of activin on the DNA
synthesis of erythroid progenitors also required the presence
of accessory cells. The dependence on accessory cells was
previously reported for the effects of platelet derived growth
factor’6 and L-tniiodothyronine.” Monocytes and/on T lym-
phocytes are known to produce various colony stimulatory
factors after appropriate stimulation.’8 It is thus conceivable
that certain humoral factor(s) were released from these
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monocytes/T lymphocytes after stimulation with activin.
However, of the currently known factors produced by these
cells, none of them exhibits specificity restricted solely to
erythroid lineage. Burst promoting activity from stimulated
T lymphocytes was characterized to be IL-3 with multileagic
specificity.’8 Another burst promoting activity was reported
to derive from B lymphocytes, but not from T lymphocytes.39
Insulin-like growth factors were known to be mitogenic for
erythroid progenitors￿#{176}’2 and, more recently, for CFU-GM
as well.4’ Furthermore, the use of serum-depleted cultures
containing 0.17 smol/L of insulin in the present study did
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